Skip to main content
Clinical Trials/NCT01908920
NCT01908920CompletedNot Applicable

Osteopathic Manipulative Treatment Effects on High Frequency Parameters in Healthy Subjects

European Institute for Evidence Based Osteopathic Medicine1 site in 1 country60 target enrollmentStarted: May 1, 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Change from baseline high frequency (HF) value at 1 week

Study Overview

Brief Summary

The aim of the present study is to determine the extend to which osteopathic manipulative treatment (OMT) is effective on a sample of healthy subjects in changing high frequency (HF) parameters.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age between 18 and 45;
  • No chronic symptomatology;
  • No acute symptomatology during the last 72 hours before intervention;
  • No pathologies

Exclusion Criteria

  • Age below 18 or over 45;
  • Pregnancy;
  • Menopause;
  • Abuse of alcool during the last 48 hours;
  • Chronic pain;
  • Acute pain during the last 72 hours;
  • Conclamate pathologies;
  • Use of drugs during the last 72 hours ;
  • Use of ortothic devices during the last 3 months;
  • Any type of surgery;
  • Osteopathic treatment during the last 3 months.

Outcomes

Primary Outcomes

Change from baseline high frequency (HF) value at 1 week

Time Frame: baseline and 1 week

Secondary Outcomes

  • Change from baseline in low frequency (LF) value at 1 week(baseline and 1 week)
  • Change from baseline LF/HF ratio value at 1 week(baseline and 1 week)
  • Change from baseline very low frequency (VLF) value at 1 week(baseline and 1 week)
  • Change from baseline standard deviation beat-to-beat (SDNN) value at 1 week(baseline and 1 week)
  • Changes from baseline square root of the mean squared difference of successive beat-to-beat (RMSSD) at 1 week(baseline and 1 week)
  • Change from baseline proportion of beat-to-beat50 divided by total number of beat-to-beats in (pNN50) at 1 week(baseline and 1 week)
  • Change from baseline detrended fluctuation scaling exponent (DFAa1) value at 1 week(baseline and 1 week)
  • Change in LF value(during treatment session)
  • Change in LF/HF ratio value(during treatment session)
  • Change in VLF value(during treatment session)
  • Change in SDNN value(during treatment session)
  • Change in RMSSD value(during treatment session)
  • Change in pNN50 value(during treatment session)
  • Change in DFAa1 value(during treatment session)
  • Change from baseline intrasubject HF value at 1 week(baseline and 1 week)
  • Change from baseline heart rate variability parameters between smokers and no-smokers at 1 week(baseline and 1 week)
  • Change from baseline 15D questionnaire at 1 week(baseline and 1 week)
  • Differences in skin conductance value between groups(1 week)

Investigators

Sponsor
European Institute for Evidence Based Osteopathic Medicine
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Francesco Cerritelli

MS, DO

European Institute for Evidence Based Osteopathic Medicine

Study Sites (1)

Loading locations...

Similar Trials